Association of Cardiovascular Outcomes With Low‐Dose Glucocorticoid Prescription in Patients With Rheumatoid Arthritis
Arthritis & Rheumatology · 2024-11 · 76 (11) · 1585-1593
DOI: 10.1002/art.42928 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 23.07.2024. Verfasst von Brian W Coburn und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Pennsylvania, Philadelphia. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Glucocorticoids, Antirheumatic Agents, Myocardial Infarction. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAMS NIH HHS, NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
Abstract (Originalsprache)
Objective
Many guidelines recommend limiting glucocorticoids in patients with rheumatoid arthritis (RA), but 40% of patients remain on glucocorticoids long term. We evaluated the cardiovascular risk of long‐term glucocorticoid prescription by studying patients on stable disease‐modifying antirheumatic drugs (DMARDs).
Methods
Using two claims databases, we identified patients with RA on stable DMARD therapy for >180 days. Proportional hazards models with inverse‐probability weights and clustering to account for multiple observations were used to estimate the effect of glucocorticoid dose on composite cardiovascular outcomes (stroke or myocardial infarction [MI]).
Results
There were 135,583 patients in Medicare and 39,272 in Optum's de‐identified Clinformatics Data Mart (CDM) database. Medicare and CDM patients had an incidence of 1.3 and 0.8 composite cardiovascular outcomes per 100 person‐years, respectively. In the older, comorbid Medicare cohort, glucocorticoids were associated with a dose‐dependent increase in composite cardiovascular outcomes in adjusted models with predicted one‐year incidence of 1.4% (95% confidence interval [CI] 1.2%–1.6%) for ≤5 mg, 1.6% (95% CI 1.4%–1.9%) for >5 to 10 mg, and 1.8% (95% CI 1.2%–2.5%) for >10 mg versus 1.1% (95% CI 1.1%–1.2%) among patients not receiving glucocorticoids. There was no significant association among the CDM cohort. However, in the subgroup of younger patients with RA and higher cardiovascular risk, glucocorticoids were associated with a dose‐dependent increase in composite cardiovascular outcomes.
Conclusion
Among older patients with more comorbidities and younger patients with higher cardiovascular risk with RA on stable DMARD therapy, glucocorticoids were associated with a dose‐dependent increased risk of MI and stroke, even at doses ≤5 mg/day. By contrast, no association was noted among younger, healthier patients with RA. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Pennsylvania, Philadelphia.
- University of Pennsylvania and Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania.
- University of Alabama at Birmingham, Birmingham.
ORCID-Profile: Brian W Coburn, Joshua F Baker, Jeffrey R Curtis, Michael D George
Förderung
- NIAMS NIH HHS
- NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- NIH
Zitieren
APA
Coburn, B. W., Baker, J. F., Hsu, J. Y., Wu, Q., Xie, F., Curtis, J. R., & George, M. D. (2024). Association of Cardiovascular Outcomes With Low‐Dose Glucocorticoid Prescription in Patients With Rheumatoid Arthritis. Arthritis & Rheumatology, 76(11), 1585-1593. https://doi.org/10.1002/art.42928
Vancouver
Coburn BW, Baker JF, Hsu JY, Wu Q, Xie F, Curtis JR, et al. Association of Cardiovascular Outcomes With Low‐Dose Glucocorticoid Prescription in Patients With Rheumatoid Arthritis. Arthritis & Rheumatology. 2024;76(11):1585-1593. doi:10.1002/art.42928
BibTeX
@article{Coburn2024,
author = {Coburn, Brian W and Baker, Joshua F and Hsu, Jesse Y and Wu, Qufei and Xie, Fenglong and Curtis, Jeffrey R and George, Michael D},
title = {Association of Cardiovascular Outcomes With Low‐Dose Glucocorticoid Prescription in Patients With Rheumatoid Arthritis},
journal = {Arthritis & Rheumatology},
year = {2024},
volume = {76},
number = {11},
pages = {1585--1593},
doi = {10.1002/art.42928}
}
EUVIMED